权益ETF系列：震荡调整，关注医药、汽车及红利板块的相对机会

Investment Rating - The report maintains an "Overweight" rating for the industry, focusing on relative opportunities in the pharmaceutical, automotive, and dividend sectors [1]. Core Insights - The report indicates a market outlook of "volatile adjustment," suggesting investors pay attention to the relative performance of the pharmaceutical, automotive, and dividend sectors [20][21]. - The A-share market is expected to experience a "V-shaped" trend, with initial gains followed by adjustments, particularly around mid-May [20]. - The report highlights that the pharmaceutical and automotive sectors have strong capital recognition, while the dividend sector remains a relatively stable option during market fluctuations [20][21]. Summary by Sections A-share Market Overview (May 19-23, 2025) - The top three broad indices were the Dividend Index (0.40%), Shenzhen Dividend (0.31%), and CSI Dividend (0.15%), while the bottom three were Northbound 50 (-3.68%), CSI 2000 (-1.52%), and Sci-Tech 50 (-1.47%) [10][12]. - The style indices showed that large-cap value (0.48%) and cyclical (0.15%) performed well, while small-cap (-1.53%) and growth (-1.50%) lagged [13][15]. - The top-performing Shenwan first-level industry indices were pharmaceutical biology (1.78%), comprehensive (1.41%), and non-ferrous metals (1.26%), with computer (-3.02%) and machinery equipment (-2.48%) at the bottom [16][18]. A-share Market Outlook (May 26-30, 2025) - The report anticipates continued volatility, with a focus on the pharmaceutical, automotive, and dividend sectors for potential relative gains [20]. - The report suggests a cautious approach to absolute return investments, while relative return opportunities in the mentioned sectors are highlighted [20][21]. - Gold stocks are also noted for potential interest due to recent price rebounds [21]. Fund Allocation Recommendations - The report recommends a balanced defensive ETF allocation strategy, emphasizing the importance of maintaining a diversified portfolio during the anticipated market adjustments [20].